Brammer Bio

Brammer Bio

Biotechnology, 250 Binney St, Cambridge, , 2142, Massachusetts, United States, 201-500 Employees

brammerbio.com

  • facebook
  • LinkedIn

phone no Phone Number: 86********

Who is BRAMMER BIO

Brammer Bio is a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies. Br...

Read More

map
  • 250 Binney St, Cambridge, Massachusetts, 2142, United States Headquarters: 250 Binney St, Cambridge, Massachusetts, 2142, United States
  • 2016 Date Founded: 2016
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BRAMMER BIO

Brammer Bio Org Chart and Mapping

Employees

Carter McCain

Senior Specialist, Global Quality Systems

Isamari Soto-Soto

Scientist II- Upstream Process Development

Christine Donnellan

Coordinator III, Maintenance

Lamont Schiller

Manufacturing Associate Iv

Hjordis Korsgren

Specialist I, Manufacturing (Fill/Finish)

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Brammer Bio

Answer: Brammer Bio's headquarters are located at 250 Binney St, Cambridge, , 2142, Massachusetts, United States

Answer: Brammer Bio's phone number is 86********

Answer: Brammer Bio's official website is https://brammerbio.com

Answer: Brammer Bio's revenue is $25 Million to $50 Million

Answer: Brammer Bio's SIC: 2834

Answer: Brammer Bio's NAICS: 325412

Answer: Brammer Bio has 201-500 employees

Answer: Brammer Bio is in Biotechnology

Answer: Brammer Bio contact info: Phone number: 86******** Website: https://brammerbio.com

Answer: Brammer Bio is a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies. Brammer offers end-to-end CDMO services from Phase I/II in Florida through commercial manufacturing in Massachusetts. Brammer Bio provides clinical and commercial supply of viral vectors for in vivo gene and ex vivo modified-cell based therapies, process and analytical development, and regulatory support, enabling large pharma and biotech clients to accelerate the delivery of novel medicines to improve patient health. The Brammer team consists of extraordinary employees focused exclusively on serving the gene therapy needs of clients and their patients. We are Helping to Cure. The management team is led by President and CEO Mark Bamforth; Chief Scientific Officer Dr. Richard Snyder, the founder of Florida Biologix, which was spun out of the University of Florida in 2015; and Chief Operating Officer Christopher Murphy. Brammer Bio offers a competitive benefits package, including medical, dental, vision, paid time off, holidays, 401(k) with a company match, incentive bonus, flexible spending account (FSA), and educational assistance.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access